139 related articles for article (PubMed ID: 38271801)
1. Targeted pH- and redox-responsive AuS/micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer.
Maghsoudian S; Motasadizadeh H; Farhadnejad H; Fatahi Y; Fathian Nasab MH; Mahdieh A; Nouri Z; Abdollahi A; Amini M; Atyabi F; Dinarvand R
Biomater Adv; 2024 Apr; 158():213771. PubMed ID: 38271801
[TBL] [Abstract][Full Text] [Related]
2. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
[TBL] [Abstract][Full Text] [Related]
3. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
5. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
6. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
7. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
8. Redox-responsive waterborne polyurethane nanocarriers for targeted doxorubicin delivery.
Mahdieh A; Motasadizadeh H; Yeganeh H; Nyström B; Dinarvand R
Int J Pharm; 2022 Nov; 628():122275. PubMed ID: 36265661
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
Jiang Y; Zhou Y; Zhang CY; Fang T
Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of amphiphilic copolymers containing zwitterionic sulfobetaine as pH and redox responsive drug carriers.
Cai M; Leng M; Lu A; He L; Xie X; Huang L; Ma Y; Cao J; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2015 Feb; 126():1-9. PubMed ID: 25531063
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
12. Comparison between novel star-like redox-sensitive amphiphilic block copolymer and its linear counterpart copolymer as nanocarriers for doxorubicin.
Murjan S; Saeedi S; Nabid MR
Drug Dev Ind Pharm; 2020 Apr; 46(4):646-658. PubMed ID: 32208035
[TBL] [Abstract][Full Text] [Related]
13. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
14. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
15. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
[TBL] [Abstract][Full Text] [Related]
16. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
[TBL] [Abstract][Full Text] [Related]
17. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
18. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
19. Reversible Cross-Linked Mixed Micelles for pH Triggered Swelling and Redox Triggered Degradation for Enhanced and Controlled Drug Release.
Xiong D; Wen L; Peng S; Xu J; Zhang L
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32178423
[TBL] [Abstract][Full Text] [Related]
20. Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.
Guo W; Deng L; Yu J; Chen Z; Woo Y; Liu H; Li T; Lin T; Chen H; Zhao M; Zhang L; Li G; Hu Y
Drug Deliv; 2018 Nov; 25(1):1103-1116. PubMed ID: 29742945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
